首页> 外国专利> Reticular nucleus multicellular double system eye implant

Reticular nucleus multicellular double system eye implant

机译:网状核多细胞双系统眼睛植入物

摘要

The invention relates to a nucleo-reticular multi-cell dual-system ocular implant, which consists of a spherical structure with calculated and variable axial length depending on the needs of the orbital cavity, made up of a mesh of cells with alternative designs which, in turn, makes up the M.M.M system, which facilitates suturing using any technique, whether in cases of evisceration or enucleation. Thanks to its multi-cell structural design, it is easy to install, with reduced risks of migration, extrusion, exposure and extraction. Since the structure has structural gaps, it offers a higher percentage of its volume for vascularisation. In addition, it contains a fibro-vascular nucleo-reticular system, which comprises a structure based on multiple levels provided with micro-reticular tissue, and intra-level filament-based communication; with the capacity to hold drugs and/or technology since it comprises a dual system with two parts that can be screwed together, capable of being manufactured in different structural designs and biocompatible materials. Model C100 manufactured with polylactic acid (PLA), an ideal material for implants, consists of 100 oval-shaped cells. Since it is a light ocular implant, it avoids depression by settling or gravity and can be manufactured in any size.
机译:本发明涉及一种核网状多电池双系统眼植入物,其包括具有计算和可变轴向长度的球形结构,这取决于轨道腔的需要,由具有替代设计的电池网组成,反过来,弥补了MMM系统,便于使用任何技术缝合,无论是在展示或enucleation的情况下。由于其多电池结构设计,易于安装,减少了迁移,挤出,暴露和提取风险。由于该结构具有结构间隙,因此其为血管化提供了更高的体积百分比。此外,它含有纤维血管核网状系统,其包括基于具有微网状组织的多个水平的结构,以及基于水平的丝网的通信;具有持有药物和/或技术的能力,因为它包括具有两个可以拧紧在一起的双系统的双系统,能够以不同的结构设计和生物相容性制造。用聚乳酸(PLA)制造的型号C100,植入物的理想材料,包括100个椭圆形细胞。由于它是一种光眼植入物,因此它通过沉降或重力来避免凹陷,并且可以以任何尺寸制造。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号